Crinetics Pharmaceuticals (CRNX) EBT Margin Growth (5y) (2022 - 2025)

Crinetics Pharmaceuticals (CRNX) EBT Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,681.27 Bn 66,680.98 Bn -
2 Nanobiotix 1,946.26 Bn 1,946.20 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 473.25 Bn 468.46 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.17 Bn 115.92 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.54 Bn 60.79 Bn 3.31 Bn
7 Belite Bio 63.20 Bn 63.20 Bn -
8 Argenx Se 56.91 Bn 51.72 Bn 1.41 Bn
9 Revolution Medicines 38.23 Bn 38.23 Bn -
10 Crinetics Pharmaceuticals 8.71 Bn 7.42 Bn 10.53 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.30 Mn
Mar 31, 2025 7.81 Mn
Mar 31, 2024 2.35 Mn
Sep 30, 2023 2.72 Mn
Jun 30, 2023 831,948.00
Mar 31, 2023 295,262.00
Dec 31, 2022 682,752.00
Sep 30, 2022 952,424.00
Jun 30, 2022 984,961.00